華神科技(000790.SZ):華神藥業擬在全國重點城市籌建大健康營銷推廣合資平台公司
格隆匯 10 月 22日丨華神科技(000790.SZ)公告,公司子公司成都中醫藥大學華神藥業有限責任公司(以下簡稱“華神藥業”)為適應未來業務發展,擬使用自有資金結合外部優質資源,在全國重點城市,包括成都、北京、上海、深圳、廣州、海南等地,共同籌建大健康營銷推廣的合資平台公司,整合銷售渠道,提升銷售業績。
投資標的的基本情況
1、註冊資本
單個公司註冊資本不超過200萬,公司投資總額不超過1000萬。
2、出資方式貨幣出資。
3、股權結構
華神藥業控股或參股,具體股權比例依據意向合作方談判確定。
4、法定代表人
根據意向合作方的合作方案確定。
5、註冊地址
擬設公司註冊地址將根據華神科技拓展區域確定,初步確定為成都、上海、北京、深圳、海南、廣州等全國重點一、二線城市及省會城市。
6、經營範圍
企業諮詢管理類、技術諮詢類、研究開發類、企業營銷策劃推廣類、包裝材料及製品銷售,與大健康相關類別的經營範圍(不限於中藥材種植及收購、不受前置許可限制的醫療器械銷售、食品、保健品銷售、電商業務等)。具體以工商局核定的經營範圍為準。
7、經營期限長期。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.